Opportunities for improving the drug development process: results from a survey of industry and the FDA
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, Mass.
National Bureau of Economic Research
2005
|
| Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
11425 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 40 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV023591538 | ||
| 003 | DE-604 | ||
| 005 | 20100310 | ||
| 007 | t | ||
| 008 | 051020s2005 xxud||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)60883177 | ||
| 035 | |a (DE-599)BVBBV023591538 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-521 |a DE-19 | ||
| 050 | 0 | |a HB1.A2 | |
| 100 | 1 | |a Berndt, Ernst R. |e Verfasser |0 (DE-588)128550783 |4 aut | |
| 245 | 1 | 0 | |a Opportunities for improving the drug development process |b results from a survey of industry and the FDA |c Ernst R. Berndt ; Adrian H.B. Gottschalk ; Matthew W. Strobeck |
| 264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2005 | |
| 300 | |a 40 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 11425 | |
| 610 | 2 | 4 | |a United States. |b Food and Drug Administration |
| 650 | 4 | |a Drug Approval |x organization & administration | |
| 650 | 4 | |a Drug Industry | |
| 650 | 4 | |a Drug development |z United States |x Evaluation | |
| 650 | 4 | |a Interinstitutional Relations | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Gottschalk, Adrian H. B. |e Verfasser |0 (DE-588)129709026 |4 aut | |
| 700 | 1 | |a Strobeck, Matthew W. |d 1972- |e Verfasser |0 (DE-588)130562637 |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
| 830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 11425 |w (DE-604)BV002801238 |9 11425 | |
| 856 | 4 | 1 | |u http://papers.nber.org/papers/w11425.pdf |z kostenfrei |3 Volltext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016906868 | ||
Datensatz im Suchindex
| _version_ | 1804138249010020352 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Berndt, Ernst R. Gottschalk, Adrian H. B. Strobeck, Matthew W. 1972- |
| author_GND | (DE-588)128550783 (DE-588)129709026 (DE-588)130562637 |
| author_facet | Berndt, Ernst R. Gottschalk, Adrian H. B. Strobeck, Matthew W. 1972- |
| author_role | aut aut aut |
| author_sort | Berndt, Ernst R. |
| author_variant | e r b er erb a h b g ahb ahbg m w s mw mws |
| building | Verbundindex |
| bvnumber | BV023591538 |
| callnumber-first | H - Social Science |
| callnumber-label | HB1 |
| callnumber-raw | HB1.A2 |
| callnumber-search | HB1.A2 |
| callnumber-sort | HB 11 A2 |
| callnumber-subject | HB - Economic Theory and Demography |
| ctrlnum | (OCoLC)60883177 (DE-599)BVBBV023591538 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01676nam a2200409zcb4500</leader><controlfield tag="001">BV023591538</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20100310 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">051020s2005 xxud||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)60883177</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023591538</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HB1.A2</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Berndt, Ernst R.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)128550783</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Opportunities for improving the drug development process</subfield><subfield code="b">results from a survey of industry and the FDA</subfield><subfield code="c">Ernst R. Berndt ; Adrian H.B. Gottschalk ; Matthew W. Strobeck</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">40 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">11425</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">United States.</subfield><subfield code="b">Food and Drug Administration</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval</subfield><subfield code="x">organization & administration</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield><subfield code="z">United States</subfield><subfield code="x">Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interinstitutional Relations</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gottschalk, Adrian H. B.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)129709026</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Strobeck, Matthew W.</subfield><subfield code="d">1972-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)130562637</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">11425</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">11425</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w11425.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016906868</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV023591538 |
| illustrated | Illustrated |
| index_date | 2024-07-02T22:41:28Z |
| indexdate | 2024-07-09T21:25:11Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016906868 |
| oclc_num | 60883177 |
| open_access_boolean | 1 |
| owner | DE-521 DE-19 DE-BY-UBM |
| owner_facet | DE-521 DE-19 DE-BY-UBM |
| physical | 40 S. graph. Darst. |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | National Bureau of Economic Research |
| record_format | marc |
| series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| spelling | Berndt, Ernst R. Verfasser (DE-588)128550783 aut Opportunities for improving the drug development process results from a survey of industry and the FDA Ernst R. Berndt ; Adrian H.B. Gottschalk ; Matthew W. Strobeck Cambridge, Mass. National Bureau of Economic Research 2005 40 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 11425 United States. Food and Drug Administration Drug Approval organization & administration Drug Industry Drug development United States Evaluation Interinstitutional Relations USA Gottschalk, Adrian H. B. Verfasser (DE-588)129709026 aut Strobeck, Matthew W. 1972- Verfasser (DE-588)130562637 aut Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 11425 (DE-604)BV002801238 11425 http://papers.nber.org/papers/w11425.pdf kostenfrei Volltext |
| spellingShingle | Berndt, Ernst R. Gottschalk, Adrian H. B. Strobeck, Matthew W. 1972- Opportunities for improving the drug development process results from a survey of industry and the FDA National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series United States. Food and Drug Administration Drug Approval organization & administration Drug Industry Drug development United States Evaluation Interinstitutional Relations |
| title | Opportunities for improving the drug development process results from a survey of industry and the FDA |
| title_auth | Opportunities for improving the drug development process results from a survey of industry and the FDA |
| title_exact_search | Opportunities for improving the drug development process results from a survey of industry and the FDA |
| title_exact_search_txtP | Opportunities for improving the drug development process results from a survey of industry and the FDA |
| title_full | Opportunities for improving the drug development process results from a survey of industry and the FDA Ernst R. Berndt ; Adrian H.B. Gottschalk ; Matthew W. Strobeck |
| title_fullStr | Opportunities for improving the drug development process results from a survey of industry and the FDA Ernst R. Berndt ; Adrian H.B. Gottschalk ; Matthew W. Strobeck |
| title_full_unstemmed | Opportunities for improving the drug development process results from a survey of industry and the FDA Ernst R. Berndt ; Adrian H.B. Gottschalk ; Matthew W. Strobeck |
| title_short | Opportunities for improving the drug development process |
| title_sort | opportunities for improving the drug development process results from a survey of industry and the fda |
| title_sub | results from a survey of industry and the FDA |
| topic | United States. Food and Drug Administration Drug Approval organization & administration Drug Industry Drug development United States Evaluation Interinstitutional Relations |
| topic_facet | United States. Food and Drug Administration Drug Approval organization & administration Drug Industry Drug development United States Evaluation Interinstitutional Relations USA |
| url | http://papers.nber.org/papers/w11425.pdf |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT berndternstr opportunitiesforimprovingthedrugdevelopmentprocessresultsfromasurveyofindustryandthefda AT gottschalkadrianhb opportunitiesforimprovingthedrugdevelopmentprocessresultsfromasurveyofindustryandthefda AT strobeckmattheww opportunitiesforimprovingthedrugdevelopmentprocessresultsfromasurveyofindustryandthefda |